Considering that multiple factors, such as IL-33, participate in the complex regulatory network of intestinal inflammation in IBD (36), it is likely that the combination of mucosal TNF with other biomarkers and clinical parameters is needed. Here, TNF is linked to inflammatory bowel disease.